Cargando…

LOXAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN STUDY

Sixty six patients of either sex with a diagnosis of schizophrenia as per DSM III-R criteria were enrolled in an open, non-comparative study. They were treated with loxapine over a duration of 6 weeks. The assessment of the patients was carried out using the Positive and Negative Syndrome Scale (PAN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emmanuel, S.A., Naidu, H., Sovani, V.B.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 1997
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967120/ https://www.ncbi.nlm.nih.gov/pubmed/21584080

Ejemplares similares

Effect of Smoking on the Pharmacokinetics of Inhaled Loxapine
por: Takahashi, Lori H., et al.
Publicado: (2014)

Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses
por: Zeller, Scott, et al.
Publicado: (2017)

Revisiting loxapine: a systematic review
por: Popovic, Dina, et al.
Publicado: (2015)

Loxapine in patient with clozapine-resistant psychosis
por: Erley, Jennifer, et al.
Publicado: (2021)

Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents
por: Citrome, Leslie
Publicado: (2013)

Effects of intravenous loxapine on systemic and brain hemodynamics
por: Lescot, T, et al.
Publicado: (2003)

Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
por: Pacciardi, Bruno, et al.
Publicado: (2019)

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
por: Faden, Justin, et al.
Publicado: (2019)

Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series
por: Cester-Martínez, Armando, et al.
Publicado: (2017)

Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time
por: Ferrer, Marc, et al.
Publicado: (2022)

Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department
por: McDowell, Marc, et al.
Publicado: (2019)

Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series
por: Roncero, Carlos, et al.
Publicado: (2017)

Loxapine to control agitation during weaning from mechanical ventilation
por: Gaudry, Stéphane, et al.
Publicado: (2017)

Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens
por: Spyker, Daniel A., et al.
Publicado: (2015)

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo‐controlled drug–drug interaction study
por: Spyker, Daniel A., et al.
Publicado: (2015)

UNDERSTANDING SCHIZOPHRENIA: A FAMILY PSYCHOEDUCATIONAL APPROACH.
por: Sovani, Anuradha
Publicado: (1993)

Considering Loxapine Instead of Clozapine: A Case Series and Literature Review
por: Shrestha, Shristi, et al.
Publicado: (2021)

A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers
por: Cassella, James V., et al.
Publicado: (2015)

The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
por: de Berardis, Domenico, et al.
Publicado: (2017)

Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
por: Im, David S., et al.
Publicado: (2023)

Loxapine to control agitation during weaning from mechanical ventilation: a randomized controlled trial
por: Gaudry, S, et al.
Publicado: (2015)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
por: Aboueid, Lila, et al.
Publicado: (2016)

Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation
por: Sztrymf, Benjamin, et al.
Publicado: (2010)

Loxapine-Induced Priapism: A Case Report and Review of the Literature on Antipsychotic-Induced Priapism
por: Dodd, Alexandra L., et al.
Publicado: (2021)

Development and validation of an HPLC-UV method for analysis of methylphenidate hydrochloride and loxapine succinate in an activated carbon disposal system
por: Bakshi, Pooja, et al.
Publicado: (2018)

Felt affect in good- and poor-outcome schizophrenia
por: Sovani, Anuradha, et al.
Publicado: (2005)

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
por: San, L., et al.
Publicado: (2017)

The in Vitro Actions of Loxapine on Dopaminergic and Serotonergic Receptors. Time to Consider Atypical Classification of This Antipsychotic Drug?
por: Ferreri, Florian, et al.
Publicado: (2017)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability
por: Schmiedl, Sven, et al.
Publicado: (2019)

Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial
por: Gil, Emilio, et al.
Publicado: (2018)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano, Jinichi, et al.
Publicado: (2013)

OPEN DRUG TRIAL WITH HALOPERIDOL DECANOATE INJECTIONS IN SCHIZOPHRENIA
por: Varma, V.K., et al.
Publicado: (1989)

Inhaled Corticosteroids for asthma treatment in India: An urgent and radical rethink needed
por: Sovani, Milind P., et al.
Publicado: (2022)

COMPARATIVE STUDY OF RISPERIDONE AND HALOPERIDOL ON CLINICAL AND PSYCHOSOCIAL PARAMETERS IN TREATMENT OF SCHIZOPHRENIA : A RANDOMISED OPEN TRIAL
por: Shrivastava, Amresh, et al.
Publicado: (2000)

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN LABEL COMPARATIVE CLINICAL TRIAL FROM NORTH INDIA
por: Avasthi, Ajit, et al.
Publicado: (2001)

Regional brain metabolism in schizophrenia: An FDG-PET study
por: Seethalakshmi, R., et al.
Publicado: (2006)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4qomjc1qji7plntkjdaqblmt9n